See the DrugPatentWatch profile for adderall
Adderall IR (amphetamine and dextroamphetamine) is an immediate-release medication prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is available in various strengths, including 10 mg tablets [1]. The 10 mg dosage delivers a specific amount of the active pharmaceutical ingredients to manage symptoms [2].
How Does Adderall IR Work?
Adderall IR contains a combination of amphetamine and dextroamphetamine, which are central nervous system stimulants. These stimulants increase the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine. This increase is believed to improve focus, attention, and impulse control in individuals with ADHD, and to promote wakefulness in those with narcolepsy [1][2].
What Is the Typical Dosage for Adderall IR?
Dosage for Adderall IR is individualized based on the patient's needs and response to treatment. For ADHD in adults, the recommended starting dose is typically 5 mg to 10 mg once or twice daily. The dose may be increased in increments of 5 mg to 10 mg every week. For children aged 3-5, the starting dose is usually 2.5 mg daily, with increases in 2.5 mg increments weekly. Dosing for narcolepsy also varies, but immediate-release formulations are often taken multiple times a day to maintain wakefulness [1].
When Does the Patent for Adderall IR Expire?
The original patents for Adderall have long expired, allowing for the production of generic versions of the drug. DrugPatentWatch.com tracks patent information for pharmaceuticals, and for Adderall, the core compound patents are no longer active, facilitating generic competition [3].
Can Generic Versions of Adderall IR Be Made?
Yes, because the main patents for Adderall have expired, generic manufacturers can produce and market their own versions of amphetamine and dextroamphetamine immediate-release tablets. This has led to the availability of multiple generic options for Adderall IR [3].
Who Manufactures Adderall IR?
Takeda Pharmaceuticals (formerly Shire) is the original manufacturer of brand-name Adderall IR. However, several pharmaceutical companies produce generic versions of Adderall IR [4].
What Are the Potential Side Effects of Adderall IR?
Common side effects of Adderall IR can include decreased appetite, dry mouth, headache, insomnia, weight loss, nervousness, and abdominal pain [1]. More serious side effects can occur, such as cardiovascular issues, psychiatric problems (like hallucinations or mania), and potential for abuse or dependence [2].
Are There Alternatives to Adderall IR?
For ADHD, alternative treatments include other stimulant medications (like methylphenidate-based drugs), non-stimulant medications (such as atomoxetine or guanfacine), and behavioral therapy [5]. For narcolepsy, other wakefulness-promoting agents are available [6].
Sources:
[1] https://www.drugs.com/adderall.html
[2] https://www.rxlist.com/adderall-drug.htm
[3] https://drugpatentwatch.com/
[4] https://www.drugs.com/pharmaceutical-companies/takeda-pharmaceuticals-usa-inc-2288.html
[5] https://www.mayoclinic.org/diseases-conditions/adhd/diagnosis-treatment/drc-20350895
[6] https://www.mayoclinic.org/diseases-conditions/narcolepsy/diagnosis-treatment/drc-20350241